Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

PTC Therapeutics Company Profile (NASDAQ:PTCT)

Consensus Ratings for PTC Therapeutics (NASDAQ:PTCT) (?)
Ratings Breakdown: 1 Hold Rating(s), 8 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $64.40 (17.18% upside)

Current Analysts' Coverage Summary for PTC Therapeutics (NASDAQ:PTCT)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/18/2014Citigroup Inc.Initiated CoverageBuy$81.00ViewTweet This Rating  Share This Rating on StockTwits
12/4/2014Credit SuisseUpgradeTop PickViewTweet This Rating  Share This Rating on StockTwits
10/13/2014Bank of AmericaReiterated RatingBuy$50.00 -> $48.00ViewTweet This Rating  Share This Rating on StockTwits
10/6/2014Cowen and CompanyDowngradeOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
9/29/2014Roth CapitalBoost Price TargetBuy$43.00 -> $58.00ViewTweet This Rating  Share This Rating on StockTwits
9/15/2014Deutsche BankInitiated CoverageBuy$75.00ViewTweet This Rating  Share This Rating on StockTwits
7/31/2014OppenheimerInitiated CoverageOutperform$60.00ViewTweet This Rating  Share This Rating on StockTwits
7/10/2014BarclaysInitiated CoverageOverweightViewTweet This Rating  Share This Rating on StockTwits
2/27/2014B. RileyInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
1/30/2014JPMorgan Chase & Co.UpgradeOverweightViewTweet This Rating  Share This Rating on StockTwits
11/8/2013WedbushBoost Price TargetOutperform$31.00 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
11/8/2013Evercore ISIBoost Price TargetOverweight$30.00 -> $34.50ViewTweet This Rating  Share This Rating on StockTwits
7/26/2013Jefferies GroupBoost Price Target$25.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/19/2012 forward)